Currencies / HROW
HROW: Harrow Inc
39.00
USD
0.01
(0.03%)
HROW exchange rate has changed by 0.03% for today. During the day, the instrument was traded at a low of 38.33 and at a high of 39.70.
Follow Harrow Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
HROW News
- Harrow appoints Andrew R. Boll as president and names Randall E. Pollard chief accounting officer
- Harrow Baby Bonds Yield Review (NASDAQ:HROW)
- Surging Earnings Estimates Signal Upside for Harrow (HROW) Stock
- Best Momentum Stock to Buy for August 15th
- Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a Bet
- Harrow Stock's Ambitious Guidance Puts It In The Proving Ground (NASDAQ:HROW)
- Harrow Stock Eyes Relative Strength Rating Upgrade
- Harrow: Exciting Times In Store (NASDAQ:HROW)
- H.C. Wainwright raises Harrow Health stock price target on VEVYE growth
- Harrow, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:HROW)
- Harrow, Inc. (HROW) Q2 2025 Earnings Call Transcript
- Harrow Health Q2 2025 slides: Mixed results amid strategic portfolio expansion
- Harrow Health earnings beat by $0.23, revenue fell short of estimates
- Barrick Gold, Roivant Sciences, Owens & Minor to report earnings Monday
- Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And More
- Harrow Health stock outlook strong as Cantor reiterates Overweight rating
- H.C. Wainwright reiterates Buy rating on Harrow Health stock at $60 target
- Harrow acquires exclusive US rights to Samsung Bioepis eye drugs
- Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar?
- Harrow's Internal $100 Price Target Is Ambitious, But Bloomberg Data Backs It Up (HROW)
- This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Harrow (NASDAQ:HROW), Janux Therapeutics (NASDAQ:JANX)
- Cantor Fitzgerald initiates Harrow Health stock with Overweight rating
- Harrow: Immense Upside Potential (NASDAQ:HROW)
Daily Range
38.33
39.70
Year Range
20.85
59.23
- Previous Close
- 38.99
- Open
- 39.44
- Bid
- 39.00
- Ask
- 39.30
- Low
- 38.33
- High
- 39.70
- Volume
- 928
- Daily Change
- 0.03%
- Month Change
- 25.60%
- 6 Months Change
- 39.73%
- Year Change
- -3.42%
31 August, Sunday